Correction to: Heregulin β1 drives gefitinib-resistant growth and invasion in tamoxifen-resistant MCF-7 breast cancer cells

Similar Items

• Heregulin β1 drives gefitinib-resistant growth and invasion in tamoxifen-resistant MCF-7 breast cancer cells
  od: Hutcheson, Iain R, i dr.
  Izdano: (2007)
• Overexpression of CD44 accompanies acquired tamoxifen resistance in MCF7 cells and augments their sensitivity to the stromal factors, heregulin and hyaluronan
  od: Hiscox, Stephen, i dr.
  Izdano: (2012)
• Overexpression of CD44 in acquired tamoxifen-resistant breast cancer cells augments their migratory response to heregulin beta 1
  od: Hiscox, S, i dr.
  Izdano: (2008)
• erbB3 recruitment of insulin receptor substrate 1 modulates insulin-like growth factor receptor signalling in oestrogen receptor-positive breast cancer cell lines
  od: Knowlden, Janice M, i dr.
  Izdano: (2011)
• Fulvestrant-induced expression of ErbB3 and ErbB4 receptors sensitizes oestrogen receptor-positive breast cancer cells to heregulin β1
  od: Hutcheson, Iain R, i dr.
  Izdano: (2011)